The Asian Fund for Cancer Research (AFCR) is proud to present the BRACE Award, Bridging Research from Academia to Cancer Entrepreneurship. The BRACE Award aims to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into the clinic, with the ultimate goal of improving outcomes for patients affected by cancer globally.
The winning company will receive up to US$600,000 in investment funding from AFCR and co-investors, subject to due diligence and negotiation, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective cancer technologies that could save patients’ lives.
2023 BRACE Award Venture Competition
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition. Degron Therapeutics, headquartered in Shanghai and with labs in the US and China, is at the forefront of developing a novel class of small molecule drugs through its molecular glue-based targeted protein degradation platform.
Sign up for e-mails to learn about future BRACE Award Competitions and other developments.